Post by
Indicator on Mar 21, 2011 2:11pm
Nice!
"... we are in a good position toreport multiple sets of data next quarter including data from thistrial and final phase II data for our pandemic influenza candidate. I amconfident that the quality of data to be obtained from these clinicaltrials and our other solid results to date will further positionMedicago as a leader in the development of rapid and cost-effectivevaccines."
Just when you resign yourself to exercising patience for the next stock move, they throw out a nice curve ball :-)
I hope everyone has been getting their fill under .50. With continued good trial results, sooner or later this has to explode.